Opportunity Information: Apply for RFA AG 18 024

The NIH grant opportunity "Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease (R24 - Clinical Trial Not Allowed)" (RFA-AG-18-024; CFDA 93.866) is focused on building shared infrastructure that helps the research community agree on clear, practical ways to define and measure cognitive reserve and resilience in the context of Alzheimer's disease and related dementias (ADRD), as well as age-related cognitive decline. Rather than funding a traditional research project or a clinical trial, the aim is to support a coordinated collaboratory that can move the field toward common operational definitions, consistent terminology, and validated, widely usable research approaches. The bigger goal is to make studies across labs and cohorts easier to compare and combine, which is essential for accelerating progress on how brain and cognitive health can be maintained and how ADRD might be treated or prevented.

A central feature of this FOA is the emphasis on convening and coordination. The supported infrastructure is meant to create and sustain a collaborative research network that brings together relevant stakeholders and experts to work through persistent scientific and methodological disagreements around what "cognitive reserve" and "resilience" mean, how they differ, and how they should be measured in real-world studies. The announcement highlights activities such as meetings and conferences to build consensus, small-scale pilot efforts to test or refine measurement approaches and frameworks, and dissemination work to promote adoption of the resulting definitions and methods. In practice, this kind of award is designed to support the "glue" of a field-wide effort: structured collaboration, iterative testing of ideas, and broad communication of recommended standards so they become the default in future ADRD and cognitive aging research.

Because the mechanism is an R24 infrastructure-type grant and explicitly indicates "Clinical Trial Not Allowed," applicants are expected to focus on resources, coordination, and methodological development rather than interventional human studies that meet NIH's definition of a clinical trial. Any pilots envisioned under the collaboratory would typically be limited in scope and oriented toward feasibility, measurement development, harmonization, or validation strategies rather than testing an intervention's effect on health outcomes. The FOA frames these activities as necessary building blocks for better science later: if the field can converge on uniform nomenclature and strong, validated approaches, subsequent observational studies and trials can be designed with clearer targets and more comparable endpoints.

Eligibility is broad and includes many types of domestic U.S. organizations: state, county, and local governments; special district governments; independent school districts; public and state-controlled universities; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly calls out additional eligible applicant types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, non-U.S. entities are not eligible to apply as applicant organizations, and non-domestic components of U.S. organizations are not eligible to apply; however, foreign components as defined by the NIH Grants Policy Statement may be allowed, which generally means a U.S.-based applicant may include certain well-justified international elements consistent with NIH policy.

In terms of funding details, the opportunity was offered by the National Institutes of Health with an original closing date of February 22, 2018. The listed award ceiling is $500,000, and the announcement indicates expected awards but does not provide a number in the provided source text. Overall, the grant is best understood as a field-building investment: creating the coordinated environment needed to sharpen definitions and standardize methods around cognitive reserve and resilience, so future ADRD and cognitive aging research can be more rigorous, comparable, and impactful.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease (R24 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2017-11-28.
  • Applicants must submit their applications by 2018-02-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 18 024

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIH RFA-AG-18-024 (R24) Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease

What is this NIH funding opportunity?

This opportunity is an NIH grant announcement titled "Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease (R24 - Clinical Trial Not Allowed)" (RFA-AG-18-024; CFDA 93.866). It supports creation of a coordinated collaboratory (shared infrastructure and coordination activities) to help the research community agree on clear, practical definitions and measurement approaches for cognitive reserve and resilience in Alzheimer's disease and related dementias (ADRD), as well as age-related cognitive decline.

What is the main goal of the award?

The main goal is to move the field toward common operational definitions, consistent terminology, and validated, widely usable research approaches for cognitive reserve and resilience. A larger objective is to make studies across labs and cohorts easier to compare and combine, helping accelerate progress in understanding and protecting brain and cognitive health and informing future ADRD treatment or prevention research.

Is this grant meant to fund a traditional research project?

No. The focus is not on a single traditional research project. The award is designed to support the infrastructure and coordination needed for field-wide consensus building, methodological alignment, and dissemination of recommended definitions and measures.

Are clinical trials allowed under this FOA?

No. The FOA explicitly states "Clinical Trial Not Allowed," so applicants are expected to avoid interventional human studies that meet NIH's definition of a clinical trial.

What types of activities does the FOA emphasize?

The FOA emphasizes convening and coordination activities such as meetings and conferences to build consensus, collaborative network-building among stakeholders and experts, dissemination efforts to promote adoption of recommended standards, and limited pilot efforts focused on measurement development, harmonization, feasibility, validation strategies, or refining frameworks.

What is meant by building "shared infrastructure" in this context?

"Shared infrastructure" refers to the organized collaboratory structure that acts as the connective tissue ("glue") for the field: structured collaboration across groups, coordinated work to resolve disagreements about definitions and measurement, iterative testing/refinement of approaches, and broad communication of outputs so they can be adopted widely.

What scientific problem is this FOA trying to solve?

The FOA targets persistent scientific and methodological disagreements about what "cognitive reserve" and "resilience" mean, how the concepts differ, and how they should be measured consistently in real-world studies. By supporting a collaboratory, NIH aims to help the community converge on uniform nomenclature and validated approaches.

Why do common definitions and measures matter for ADRD and cognitive aging research?

Common definitions and measures make it easier to compare findings across labs and cohorts and to combine datasets. This consistency is described as essential for accelerating progress on how brain and cognitive health can be maintained and how ADRD might be treated or prevented.

What kinds of pilot projects are appropriate under this R24?

Any pilots should generally be small in scope and oriented toward feasibility, measurement development, harmonization, or validation strategies, rather than testing an intervention's effect on health outcomes.

What is the grant mechanism used for this opportunity?

The opportunity uses the R24 mechanism, described here as an infrastructure-type award intended to support coordinated, collaborative activities and methodological development.

Who is eligible to apply?

Eligibility is broad and includes many types of domestic U.S. organizations, including state, county, and local governments; special district governments; independent school districts; public and state-controlled universities; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses.

Are minority-serving institutions and community-based organizations eligible?

Yes. The FOA explicitly calls out additional eligible applicant types including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, and faith-based or community-based organizations. It also mentions eligible federal agencies, regional organizations, and U.S. territories or possessions.

Can non-U.S. organizations apply as the main applicant?

No. Non-U.S. entities are not eligible to apply as applicant organizations, and non-domestic components of U.S. organizations are not eligible to apply.

Are foreign components allowed in any way?

Foreign components (as defined by the NIH Grants Policy Statement) may be allowed. In general terms based on the provided information, this means a U.S.-based applicant may include certain well-justified international elements consistent with NIH policy.

Which NIH institute is offering this opportunity?

The opportunity is offered by the National Institutes of Health (NIH).

What is the CFDA number for this opportunity?

The CFDA number provided is 93.866.

What is the maximum award amount mentioned?

The listed award ceiling is $500,000.

When did this opportunity close?

The original closing date listed is February 22, 2018.

Does the provided information specify how many awards NIH expected to make?

No. The announcement indicates expected awards, but the provided text does not include the number of expected awards.

What does success look like for a project funded under this FOA?

Based on the description, success would look like a sustained collaboratory that brings experts together to reach practical consensus on definitions and measurement of cognitive reserve and resilience, produces validated and usable methodological recommendations, and disseminates them broadly so they become commonly adopted standards in ADRD and cognitive aging research.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required

Previous opportunity: SAECP � Secondary Agriculture Education Challenge Grant Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 18 024

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 18 024) also looked into and applied for these:

Funding Opportunity
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) Apply for PA 18 276

Funding Number: PA 18 276
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01 Clinical Trial Optional) Apply for PA 18 281

Funding Number: PA 18 281
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional) Apply for PAR 18 263

Funding Number: PAR 18 263
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
NINDS Efficacy Clinical Trials (U01) - Clinical Trial Required Apply for PAR 18 422

Funding Number: PAR 18 422
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Exploratory Clinical Trials (U01 - Clinical Trials Required) Apply for PAR 18 420

Funding Number: PAR 18 420
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 - Clinical Trials Required) Apply for PAR 18 417

Funding Number: PAR 18 417
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 125

Funding Number: PAR 18 125
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01 Clinical Trial Optional) Apply for PAR 18 133

Funding Number: PAR 18 133
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Program Project Grant (P01) - Clinical Trial Optional Apply for PAR 18 421

Funding Number: PAR 18 421
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20 Clinical Trial Optional) Apply for PAR 18 264

Funding Number: PAR 18 264
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed) Apply for RFA AI 17 042

Funding Number: RFA AI 17 042
Agency: National Institutes of Health
Category: Health
Funding Amount: $5,000,000
Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 Clinical Trial Optional) Apply for PAR 18 265

Funding Number: PAR 18 265
Agency: National Institutes of Health
Category: Health
Funding Amount: $4,000,000
Centers of Biomedical Research Excellence (COBRE) (P20 Clinical Trial Optional) Apply for PAR 18 266

Funding Number: PAR 18 266
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Youth Violence Prevention Interventions that Incorporate Racism/Discrimination Prevention (R01-Clinical Trial Required) Apply for RFA MD 18 005

Funding Number: RFA MD 18 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NIBIB Research Project Grant (R01 Clinical Trial Required) Apply for PA 18 418

Funding Number: PA 18 418
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH-CASIS Coordinated Microphysiological Systems Program for Translational Research in Space (UG3/UH3) (Clinical Trials Not Allowed) Apply for RFA TR 18 001

Funding Number: RFA TR 18 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Research on Pre-Exposure Prophylaxis (PrEP) to Prevent HIV in Health Disparity Populations (R01-Clinical Trial Not Allowed) Apply for RFA MD 18 003

Funding Number: RFA MD 18 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
NHLBI Clinical Trial Pilot Studies (R34 - Clinical Trial Optional) Apply for PAR 18 463

Funding Number: PAR 18 463
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) Apply for RFA AI 17 040

Funding Number: RFA AI 17 040
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,400,000
Understanding Immunopathogenesis of Tuberculosis in HIV-1 Infected and Exposed Children (R01 Clinical Trial Not Allowed) Apply for RFA AI 17 039

Funding Number: RFA AI 17 039
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 18 024", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: